AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company products include AcouTrap, AcouWash, and AcouPlasma.
2010
17
Last FY Revenue $0.5M
Last FY EBITDA -$1.5M
$7.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, AcouSort achieved revenue of $0.5M and an EBITDA of -$1.5M.
AcouSort expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See AcouSort valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.5M | XXX | XXX | XXX |
Gross Profit | XXX | $0.5M | XXX | XXX | XXX |
Gross Margin | XXX | 101% | XXX | XXX | XXX |
EBITDA | XXX | -$1.5M | XXX | XXX | XXX |
EBITDA Margin | XXX | -298% | XXX | XXX | XXX |
EBIT | XXX | -$1.7M | XXX | XXX | XXX |
EBIT Margin | XXX | -340% | XXX | XXX | XXX |
Net Profit | XXX | -$1.6M | XXX | XXX | XXX |
Net Margin | XXX | -318% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, AcouSort's stock price is SEK 3 (or $0).
AcouSort has current market cap of SEK 73.2M (or $7.6M), and EV of SEK 69.8M (or $7.2M).
See AcouSort trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$7.2M | $7.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, AcouSort has market cap of $7.6M and EV of $7.2M.
AcouSort's trades at 14.7x EV/Revenue multiple, and -4.9x EV/EBITDA.
Equity research analysts estimate AcouSort's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AcouSort's P/E ratio is not available.
See valuation multiples for AcouSort and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $7.6M | XXX | $7.6M | XXX | XXX | XXX |
EV (current) | $7.2M | XXX | $7.2M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 14.7x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -4.9x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -4.3x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -4.9x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -3.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAcouSort's revenue per employee in the last FY averaged $29K, while opex per employee averaged $0.1M for the same period.
AcouSort's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AcouSort's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for AcouSort and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | 133% | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -298% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $29K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 441% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AcouSort acquired XXX companies to date.
Last acquisition by AcouSort was XXXXXXXX, XXXXX XXXXX XXXXXX . AcouSort acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was AcouSort founded? | AcouSort was founded in 2010. |
Where is AcouSort headquartered? | AcouSort is headquartered in Sweden. |
How many employees does AcouSort have? | As of today, AcouSort has 17 employees. |
Is AcouSort publicy listed? | Yes, AcouSort is a public company listed on STO. |
What is the stock symbol of AcouSort? | AcouSort trades under ACOU ticker. |
When did AcouSort go public? | AcouSort went public in 2020. |
Who are competitors of AcouSort? | Similar companies to AcouSort include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of AcouSort? | AcouSort's current market cap is $7.6M |
Is AcouSort profitable? | Yes, AcouSort is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.